Potential additive effects of garcinia cambogia on atorvastatin treated hyperlipidemic patients: randomized crossover clinical study
نویسندگان
چکیده
منابع مشابه
Garcinia (Garcinia cambogia), Hydroxycitric acid
1 of 5 12/11/07 3:10 PM Garcinia (Garcinia cambogia), Hydroxycitric acid Natural Standard Bottom Line Monograph, Copyright © 2007 (www.naturalstandard.com). Commercial distribution prohibited. This monograph is intended for informational purposes only, and should not be interpreted as specific medical advice. You should consult with a qualified healthcare provider before making decisions about ...
متن کاملGarcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.
CONTEXT Hydroxycitric acid, the active ingredient in the herbal compound Garcinia cambogia, competitively inhibits the extramitochondrial enzyme adenosine triphosphate-citrate (pro-3S)-lyase. As a citrate cleavage enzyme that may play an essential role in de novo lipogenesis inhibition, G cambogia is claimed to lower body weight and reduce fat mass in humans. OBJECTIVE To evaluate the efficac...
متن کاملGarcinia Cambogia, Diabetic Ketoacidosis, and Pancreatitis.
[Full article available at http://rimed.org/rimedicaljournal-2017-10.asp].
متن کاملEffects of additive therapy with spironolactone on albuminuria in diabetes mellitus: A pilot randomized clinical trial
Background: Early diagnosis of albuminuria and the prevention of its progression to macroalbuminuria and diabetic nephropathy are crucial. Angiotensin converting enzyme inhibitors (ACEIs) and antagonists of angiotensin II receptors type I (ARBs) are currently used as first-line treatment for albuminuria in these patients. The present study was conducted to assess the efficacy of addition of spi...
متن کاملEffects of garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial.
BACKGROUND (-)-Hydroxycitric acid (HCA) is an active ingredient extracted from the rind of the Indian fruit Garcinia cambogia. It inhibits adenosine triphosphate citrate lyase and has been used in the treatment of obesity. OBJECTIVE The primary end point of this study was the effects of 12 weeks of G cambogia extract administration on visceral fat accumulation. The secondary end points were b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Advances in Medicine
سال: 2014
ISSN: 2349-3925
DOI: 10.5455/2349-3933.ijam20141121